Bausch Health Companies (BHC) Intangibles (2009 - 2026)
Bausch Health Companies (BHC) posted Intangibles of $4.2 billion for Q2 2026, down 5.11% sequentially from $4.4 billion in Q1 2026, and down 17.2% YoY from $5.0 billion in Q2 2025.
Bausch Health Companies (BHC) Intangibles (2009 - 2026) Analysis & Trends
Bausch Health Companies has reported Intangibles for 18 years, with the latest figure at $4.2 billion in Q2 2026.
- Quarterly Intangibles fell 17.2% year-over-year to $4.2 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $4.2 billion (down 17.2% YoY) and the FY2025 annual result came in at $4.6 billion, down 16.36% from the prior year.
- Intangibles slipped to $4.2 billion in Q2 2026 per BHC's latest filing, from $4.4 billion in the prior quarter.
- Over five years, Intangibles peaked at $6.7 billion in Q3 2023 and troughed at $4.2 billion in Q2 2026.
- A 5-year average of $5.6 billion and a median of $5.6 billion in 2023 frame the typical range for Intangibles.
- The sharpest annual moves came in 2023 and 2026: Intangibles grew 11.69% in 2023, then fell 17.2% in 2026.
- Over 5 years, Intangibles stood at $5.8 billion in 2022, then gained by 11.31% to $6.5 billion in 2023, then decreased by 14.02% to $5.6 billion in 2024, then dropped by 16.36% to $4.6 billion in 2025, then fell by 9.99% to $4.2 billion in 2026.
- According to Business Quant data, Intangibles over the past three periods registered $4.2 billion, $4.4 billion, and $4.6 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 3.45 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 918.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 21.28 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 13.68 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 2.23 Bn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 3.20 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 1.12 Bn |
| 10 | Bausch Health Companies | 2.42 Bn | 586.38 Mn | 2.10 Bn | 4.18 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.18 Bn |
| Mar 31, 2026 | 4.40 Bn |
| Dec 31, 2025 | 4.64 Bn |
| Sep 30, 2025 | 4.83 Bn |
| Jun 30, 2025 | 5.05 Bn |
| Mar 31, 2025 | 5.30 Bn |
| Dec 31, 2024 | 5.55 Bn |
| Sep 30, 2024 | 5.65 Bn |
| Jun 30, 2024 | 5.90 Bn |
| Mar 31, 2024 | 6.18 Bn |
| Dec 31, 2023 | 6.46 Bn |
| Sep 30, 2023 | 6.73 Bn |
| Jun 30, 2023 | 5.30 Bn |
| Mar 31, 2023 | 5.55 Bn |
| Dec 31, 2022 | 5.80 Bn |
| Sep 30, 2022 | 6.02 Bn |
| Jun 30, 2022 | 6.32 Bn |
| Mar 31, 2022 | 6.63 Bn |
| Dec 31, 2021 | 6.95 Bn |
| Sep 30, 2021 | 7.26 Bn |